MicroRNA-17, MicroRNA-18a, and MicroRNA-19a are prognostic indicators in esophageal squamous cell carcinoma

Annals of Thoracic Surgery

Volumn 97, Issue 3, 2014, Pages 1037-1045

  Xu, Xiao Ling ^a   Jiang, You Hua ^a   Feng, Jian Guo ^a   Su, Dan ^a   Chen, Peng Cheng ^a   Mao, Wei Min ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE; GENE CLUSTER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICRORNA 17 GENE; MICRORNA 18A GENE; MICRORNA 19A GENE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS;

EID: 84896704806     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.10.042     Document Type: Article

References (37)

1. P.C. Enzinger, and R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241 2252
2. T. Hiyama, M. Yoshihara, S. Tanaka, and K. Chayama Genetic polymorphisms and esophageal cancer risk Int J Cancer 121 2007 1643 1658
3. J.R. Headrick, F.C. Nichols 3rd, and D.L. Miller et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy Ann Thorac Surg 73 2002 1697 1702 discussion 1702-3
4. A. Bharat, and T. Crabtree Management of advanced-stage operable esophageal cancer Surg Clin North Am 92 2012 1179 1197
5. W.M. Korn Prevention and management of early esophageal cancer Curr Treat Options Oncol 5 2004 405 416
6. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
7. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
8. P. Trang, P.P. Medina, and J.F. Wiggins et al. Regression of murine lung tumors by the let-7 microRNA Oncogene 29 2010 1580 1587
9. P.P. Medina, M. Nolde, and F.J. Slack OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 467 2010 86 90
10. X. Jiao, L. Zhao, and M. Ma et al. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2) Breast Cancer Res Treat 139 2013 717 730
11. Y. Wang, J. Gu, and J.A. Roth et al. Pathway-based serum microRNA profiling and survival in patients with advanced non-small cell lung cancer Cancer Res 73 2013 4801 4809
12. T. Sun, X. Wang, and H.H. He et al. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A Oncogene 2013 [Epub ahead of print]
13. E. Calura, R. Fruscio, and L. Paracchini et al. miRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities Clin Cancer Res 19 2013 4414 4423
14. J.T. Mendell miRiad roles for the miR-17-92 cluster in development and disease Cell 133 2008 217 222
15. A. Tsuchida, S. Ohno, and W. Wu et al. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer Cancer Sci 102 2011 2264 2271
16. A. Ota, H. Tagawa, and S. Karnan et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma Cancer Res 64 2004 3087 3095
17. L. He, J.M. Thomson, and M.T. Hemann et al. A microRNA polycistron as a potential human oncogene Nature 435 2005 828 833
18. W. Wu, M. Takanashi, and N. Borjigin et al. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis Br J Cancer 108 2013 653 661
19. H. Matsubara, T. Takeuchi, and E. Nishikawa et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 Oncogene 26 2007 6099 6105
20. Y. Hayashita, H. Osada, and Y. Tatematsu et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Cancer Res 65 2005 9628 9632
21. R. Morimura, S. Komatsu, and D. Ichikawa et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer Br J Cancer 105 2011 1733 1740
22. J. Guo, Y. Miao, and B. Xiao et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues J Gastroenterol Hepatol 24 2009 652 657
23. Y.X. Wang, X.Y. Zhang, and B.F. Zhang et al. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis J Dig Dis 11 2010 50 54
24. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
25. B. Diosdado, M.A. van de Wiel, and J.S. Terhaar Sive Droste et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression Br J Cancer 101 2009 707 714
26. K. Woods, J.M. Thomson, and S.M. Hammond Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors J Biol Chem 282 2007 2130 2134
27. Y. Lu, J.M. Thomson, H.Y. Wong, S.M. Hammond, and B.L. Hogan Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells Dev Biol 310 2007 442 453
28. M. Liu, Z. Wang, and S. Yang et al. TNF-α is a novel target of miR-19a Int J Oncol 38 2011 1013 1022
29. J. Loven, N. Zinin, and T. Wahlstrom et al. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma Proc Natl Acad Sci U S A 107 2010 1553 1558
30. S. Yabushita, K. Fukamachi, and H. Tanaka et al. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas Pancreas 41 2012 1013 1018
31. C.W. Wu, Y.J. Dong, and Q.Y. Liang et al. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer PLoS One 8 2013 e57036
32. J. Yu, K. Ohuchida, and K. Mizumoto et al. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion Cancer Biol Ther 10 2010 748 757
33. M. Dews, A. Homayouni, and D. Yu et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat Genet 38 2006 1060 1065
34. Z. Yu, C. Wang, and M. Wang et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation J Cell Biol 182 2008 509 517
35. W.H. Liu, S.H. Yeh, and C.C. Lu et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells Gastroenterology 136 2009 683 693
36. L. Song, C. Lin, and Z. Wu et al. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase PLoS One 6 2011 e25454
37. M. Inomata, H. Tagawa, and Y.M. Guo et al. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes Blood 113 2009 396 402